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Olig2/Plp-positive progenitor cells give rise to
Bergmann glia in the cerebellum
S-H Chung1, F Guo2, P Jiang1, DE Pleasure2,3 and W Deng*,1,3,4
NG2 (nerve/glial antigen2)-expressing cells represent the largest population of postnatal progenitors in the central nervous
system and have been classified as oligodendroglial progenitor cells, but the fate and function of these cells remain incompletely
characterized. Previous studies have focused on characterizing these progenitors in the postnatal and adult subventricular zone
and on analyzing the cellular and physiological properties of these cells in white and gray matter regions in the forebrain. In the
present study, we examine the types of neural progeny generated by NG2 progenitors in the cerebellum by employing genetic
fate mapping techniques using inducible Cre–Lox systems in vivowith two different mouse lines, the Plp-Cre-ERT2/Rosa26-EYFP
and Olig2-Cre-ERT2/Rosa26-EYFP double-transgenic mice. Our data indicate that Olig2/Plp-positive NG2 cells display
multipotential properties, primarily give rise to oligodendroglia but, surprisingly, also generate Bergmann glia, which are
specialized glial cells in the cerebellum. The NG2þ cells also give rise to astrocytes, but not neurons. In addition, we show that
glutamate signaling is involved in distinct NG2þ cell-fate/differentiation pathways and plays a role in the normal development of
Bergmann glia. We also show an increase of cerebellar oligodendroglial lineage cells in response to hypoxic–ischemic injury,
but the ability of NG2þ cells to give rise to Bergmann glia and astrocytes remains unchanged. Overall, our study reveals a novel
Bergmann glia fate of Olig2/Plp-positive NG2 progenitors, demonstrates the differentiation of these progenitors into various
functional glial cell types, and provides significant insights into the fate and function of Olig2/Plp-positive progenitor cells in
health and disease.
Cell Death and Disease (2013) 4, e546; doi:10.1038/cddis.2013.74; published online 14 March 2013
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NG2 (nerve/glial antigen2) is a chondroitin sulfate proteogly-
can. Progenitor cells that express NG2 (termed ‘NG2þ cells’)
constitute 5–8% of cells in the central nervous system,1,2 but
their fate and function in health and disease still remain
controversial. These progenitor cells can be identified by the
expression of several additional molecular markers, including
platelet-derived growth factor receptor-a (PDGFRa) and Olig2
proteins, and the proteolipid (Plp) promoter. NG2þ cells have
been classified as oligodendrocyte precursor cells (OPCs),
although they can also generate type-2 astrocytes in vitro.3,4
Accumulating evidence using various lines of genetic cell-fate
mapping mice reveals multiple fates of NG2 cells in vivo.
These include interneurons,5–7 principal neurons,8–10 and
astrocytes.10–13 However, a recent report concluded that the
only fate for NG2þ cells is to become oligodendrocytes.14
In the present study, we employed both tamoxifen-inducible
Plp15 and Olig2,16–18 the Cre transgenes to ascertain the fates
of NG2þ cells in the pre- and postnatal cerebellum, and
found that, in addition to oligodendroglia, they give rise to
astroglia after prenatal tamoxifen administration, and to
Bergmann glia (BG) after postnatal tamoxifen administration.
Thus, cerebellar NG2þ cells are multipotential. Furthermore,
we employed inhibitors of ionotropic glutamate receptors to
evaluate whether glutamate signaling is involved in NG2þ
cell-fate/differentiation pathways by tracing the fates of the
extended yellow fluorescent protein (EYFP)-positive cells,
and found evidence suggesting that glutamate receptors play
a role in the normal development of BG. We also reveal that,
despite a reactive response to injury, the multiple lineage
potential of NG2þ cells remains unchanged in the cerebellum
in a hypoxic–ischemic model of neonatal brain injury.19,20
Thus, our work reveals a novel BG fate of Olig2/Plp-positive
NG2 progenitors, and provides important insights into the fate
and function of the NG2þ progenitors in health and disease.
This study explores a controversial area and defines the
developmental potential of the NGþ cells of the cerebellum.
Previous studies have reported a number of divergent results
on the fates of NG2þ cells. Our work provides strong weight
to the view that NG2þ cells readily generate oligodendro-
cytes as well as astrocytes, but do not generate neurons.
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Our study also makes the crucial point that the outcomes of
the NG2þ cell-fate mapping experiments can be markedly
different, depending upon the time point at which Cre-
dependent labeling is initiated, and the surprising result is
that NG2þ cells can give rise to BG late in cerebellar
development.
Results
Plp-expressing NG2þ cells primarily generate
oligodendrocytes in the cerebellum. The Plp gene
encodes an integral membrane proteolipid protein and its
smaller isoform DM-20, which together constitute 450% of
the total protein in CNS myelin. Postnatal Plp promoter activity
is largely confined to oligodendroglial lineage cells.21–24 To
examine NG2þ cell fates in the developing mouse cerebel-
lum, we used Plp-Cre-ERT2/Rosa26-EYFP (PCE/R) double-
transgenic mice9,13 to identify tamoxifen-inducible cerebellar
expression of Plp-positive progenitor cells and their progeny.
When tamoxifen was injected at postnatal day 7 (P7), strong
EYFP immunoreactivity was observed throughout the P60
cerebellum (Figure 1a). Specific EYFP immunoreactivity was
shown in the molecular and the Purkinje cell layers (Figures 1 a
and a’). Earlier tamoxifen injection at embryonic day 19.5
(E19.5) exhibited a similar expression pattern (Figure 1b).
Diffuse EYFP-positive cells were observed throughout the
Purkinje cell and the molecular layers (Figure 1b). A number of
EYFP-positive cells were also observed in the white matter
track (Figures 1c and d). In the white matter, many of these
EYFP-positive cells expressed immature oligodendrocyte
marker, NG2 (Figures 1e–g; B32.6% (127/390, tamoxifen
injection (t.i.) at E19.5, analyzed at P8),B22.3% (194/869, t.i.
at E19.5, analyzed at P15), andB16.6% (114/687, t.i. at P7,
analyzed at P60) were double labeled (n¼ 6 mice/group)).
To further examine whether Plp-expressing NG2þ
progenitor cells differentiate into oligodendrocytes, t.i. was
given at E19.5 or P7, and sections from P15 or P60,
respectively, were examined by double immunohistochem-
istry with several oligodendroglial lineage markers, including
the pan-lineage marker Olig2 (Figures 1i and k), the
oligodendrocyte precursor marker PDGFRa (Figures 1l and
m), and a marker for both immature and mature oligoden-
drocytes, O1 (Figures 1h and j). Immunofluorescence staining
showed that a large proportion of EYFP-positive cells were
colabeled with Olig2 (Figures 1i and k). The extent to which
Plp-expressing NG2þ cells gave rise to oligodendrocytes
varied in different cerebellar areas we assessed. In the white
matter, double-immunofluorescence labeling with anti-EYFP
and anti-Olig2 revealed that B66% (193/293, t.i. at E19.5,
analyzed at P15) andB78% (184/237, t.i. at P7, analyzed at
P60) of EYFPþ cells expressed Olig2 (Figures 1i, k, and n)
(n¼ 6 mice). A subset of EYFP-positive profiles coexpressed
O1 (Figures 1h, j, and n, B57% (98/172, t.i. at E19.5,
analyzed at P15) andB63% (151/241, t.i. at P7, analyzed at
P60) were double labeled). However, PDGFRa-positive
profiles were relatively few (Figures 1l, m, and n;B18% (21/
120 t.i. at E19.5, analyzed at P15) andB1% (1/98, t.i. at P7,
analyzed at P60) were double labeled; n¼ 6 mice). Consistent
with previous findings on NG2þ cell fates, these data indicate
that NG2þ cells give rise primarily to oligodendrocytes.
Plp-expressing NG2þ cells also give rise to astrocytes
and BG in the cerebellum. NG2þ progenitor cells can
generate oligodendrocytes or type-2 astrocytes in vitro,
depending on the composition of the culture medium.3 We
examined EYFP-positive cells for glial fibrillary acidic protein
(GFAP) expression in the cerebellum of the PCE/R mice in
which tamoxifen was administered at E19.5 and cerebellar
sections analyzed at P15. Consistent with previous data
analyzed in the forebrain using the same Plp-Cre mouse
line,9,13 many of the EYFP-positive cells in the granular layer
expressed GFAP (Figures 2a and 3a), indicating that Plp-
expressing NG2þ cells gave rise to astrocytes in the
cerebellum. Surprisingly, later t.i. revealed a dramatic profile
of EYFP-positive BG throughout the cerebellum (Figures 2b
and h and 3b). BG were not labeled to the same extent with
fetal administration of tamoxifen. In addition, the number of
EYFPþ BG was significantly increased at P60 (t.i. at P7)
compared with P15 (t.i. at E19.5; Po0.01; Figure 3b). BG
are specialized glia in the cerebellum that are located in
proximity to the soma of Purkinje cells, and extending their
processes through the molecular layer to terminate at the pial
surface.25 To confirm the localization of EYFP to BG, double
immunostaining was performed with several cell type-
specific markers. Double staining with the pan-neuronal
marker NeuN revealed that EYFP immunoreactivity was not
present in neurons (Figure 2b and 3c), and staining with the
pan-oligodendroglial marker Olig2 indicated that these
EYFPþ cells were not oligodendroglia at all postnatal ages
(P15 was shown as an example; Figure 3d). Double staining
was performed to label calbindin binding protein (CaBP), a
specific marker for all adult Purkinje cells,26–28 together with
EYFP. EYFP-positive cells were CaBP-negative (Figure 3e).
These results clearly indicate that Plp-expressing NG2þ
cells give rise to astrocytes and BG in the mouse cerebellum
in an age-dependent manner.
Olig2-expressing NG2þ cells differentiate into
oligodendrocytes, astrocytes, and BG, but not neurons.
To corroborate the results on the fates of the Plp-expressing
NG2þ cells, and to further confirm that NG2 progenitor cells
could give rise to multiple cell types in the cerebellum,
we next generated transgenic Olig2-CreERT2/Rosa26-EYFP
(OCE/R) mice. Olig2 is a basic helix-loop-helix (bHLH)
transcription factor that is expressed in NG2þ progenitor
lineage cells from embryonic to adult stages.16–18 Strong and
specific EYFP immunoreactivity was observed throughout
the cerebellum (Figures 4a and b). A number of EYFP-
positive cells were observed in the white matter (Figures
4a and b). Double immunofluorescence labeling of EYFP and
the oligodendrocyte lineage marker O1 or PDGFRa revealed
thatB77% (135/175, t.i. at P6, analyzed at P11) of EYFPþ
cells expressed O1, whereas B16% (35/217, t.i. at P6,
analyzed at P11; n¼ 6 mice) of EYFPþ cells expressed
PDGFRa. These data further confirm that the majority of
EYFP-positive cells in cerebellar white matter give rise to
oligodendrocytes (Figures 4c and d).
We next examined whether Olig2-expressing NG2þ
progenitor cells could also give rise to astrocytes and BG in
the cerebellum. Immunostaining of a transverse section
revealed that anti-GFAP immunoreactivity was present in
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the somata and processes of astrocytes (Figures 5a and h)
and BG (Figures 5b,d, and i ) in the granular layer. The
percentile of EYFPþ astrocytes and BG was dependent on
the age of the mice. P8 cerebellum (t.i. at P5) showed B6%
(16/276) astrocytes andB16% (27/172) BG of EYFPþ cells,
whereas P11 cerebellum (t.i. at P6) revealedB13% (39/302)
astrocytes andB29% (61/211) BG of EYFPþ cells (Po0.05;
n¼ 6 mice). Thus, consistent with our Plp-Cre fate mapping
data, these results further confirm that that Olig2-expressing
NG2þ cells can give rise to astrocytes and BG in the mouse
cerebellum.
NG2þ cells do not give rise to neurons in the mouse
cerebellum. Whether NG2þ cells can give rise to
neurons is controversial. To determine whether Olig2-
expressing NG2þ cells generate EYFP-positive neurons,
we co-immunostained for EYFP and NeuN. We did not find
any EYFPþ /NeuNþ cells throughout the cerebellum of
these mice (Figures 6a–c). Further analysis confirmed the
lack of EYFPþ /NeuNþ neurons at different ages of the
mice and time points we examined, and we did not find any
ectopic expression of Olig2-driven EYFP in the OCE/R mice
24 h after tamoxifen treatment.
Figure 1 Expression pattern of Plp-expressing NG2þ cells in the mouse cerebellum: Plp-expressing NG2þ cells primarily generate oligodendrocytes. (a)
Sagittal sections of the postnatal day 60 (P60) Plp-Cre-ERT2/Rosa26-EYFP (PCE/R) double-transgenic mouse cerebellum immunofluorescence stained with anti-GFP after
tamoxifen injection (t.i.) at P7. Strong and specific EYFP-positive cells were observed throughout the cerebellum. (a’) A higher magnification view of a rectangle area in (a).
(b) Sagittal sections of the PCE/R double-transgenic mouse cerebellum immunofluorescence stained with anti-GFP. Tamoxifen was injected at embryonic day 19.5 (E19.5)
and sections analyzed at P15. Specific immunoreactivity encompassing both somata and cellular processes was seen in the molecular and the Purkinje cell layers. (c and d):
EYFP-positive cells were present in the white matter of the cerebellum at P60 (c) and P15 (d). (e and f) Double immunofluorescence with anti-GFP and the immature
oligodendrocyte marker, anti-NG2 showed a colocalization in the white matter of the cerebellum. (g) Quantification of the percentile of EYFP-positive cells immunoreactive for
NG2. As the distribution of oligodendrocyte lineage cells was concentrated in the white matter region of the cerebellum, the counting was performed in the white matter. (h and j):
P15 (h) and P60 (j) PCE/R cerebellar sagittal sections were double immunofluorescence stained with anti-GFP and anti-O1. Tamoxifen was injected at E19.5 or P7, respectively.
(i and k): P15 (i) and P60 (k) cerebellar sagittal sections were double immunofluorescence stained with anti-GFP and anti-Olig2. Tamoxifen was injected at E19.5 or P7,
respectively. (l and m): P15 (l) and P60 (m) cerebellar sagittal sections were double immunofluorescence stained with anti-GFP and anti-PDGFRa. Tamoxifen was injected at
E19.5 or P7, respectively. (n) Quantification of the percentile of EYFP-positive cells in the white matter that were immunoreactive for Olig2, O1, or PDGFRa. Abbreviations: CN,
cerebellar nuclei; gl, granule cell layer; ml, molecular layer; pcl, Purkinje cell layer; PPEP, Plp-expressing progenitor cells; t.i., tamoxifen injection; wm, white matter. Scale bars:
(a and b)¼ 150mm; (a’, c, and d)¼ 50mm; (f, e, k, h–m)¼ 25mm
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We next sought to investigate whether Plp-expressing
NG2þ cells could generate EYFP-positive neurons in the
mouse cerebellum of PCE/R mice. We immunostained for
EYFP and NeuN in the cerebellum of P15 (t.i. at E19.5) and
P60 (t.i. at P7) PCE/R mice. When tamoxifen was injected at
E19.5, a very small number of EYFPþ cells expressed NeuN,
a pan-neuronal marker, and they could only be found in the
cerebellar nuclei region (B0.7%, 5/683; Figures 6d–f).
We did not find any EYFPþ /NeuNþ neurons in any other
areas of the cerebellum, and thus the actual percentile of
NeuNþ neurons in all EYFPþ cells was very small. In
addition, we found that a very small number of EYFPþ /
NeuNþ neurons were already apparent 24 h after tamoxifen
treatment (Figure 6h), and again those few neurons ectopi-
cally expressing EYFP were only found in the cerebellar nuclei
region (Figures 6h and i), indicating that they must have been
already neurons or nearly differentiated neurons that hap-
pened to express the Plp promoter at the time of tamoxifen
treatment. These results indicate that NG2þ cells do not give
rise to neurons in the mouse cerebellum.
Glutamate receptor antagonist treatment generally does
not alter the fates of NG2þ cells, but the development of
BG is impaired. Given the BG fate of NG2þ progenitors,
we next sought to examine possible mechanisms of the cell-
fate control in the mouse cerebellum. Given the previously
known role of glutamate-triggered calcium signaling
in shaping the BG cell fate in mice,29,30 we used the
N-Methyl-D-aspartate (NMDA) glutamate receptor antago-
nist dizocilpine maleate (MK-801) and the non-NMDA
glutamate receptor antagonist 2,3-dihydroxy-6-nitro-7-sulfa-
moylbenzo(f) quinoxaline-2,3-dione (NBQX) to evaluate the
effects of ionotropic glutamate receptor signaling on the
generation of BG from NG2þ cells in PCE/R mice.
Figure 3 Plp-expressing NG2þ cells also give rise to astrocytes and BG (Part 2). (a and b) Quantification of the percentile of EYFPþGFAPþ cells out of the
whole GFAPþ cells in the white matter. The number of EYFPþ BG glia was significantly increased at P60 (t.i. at P7) compared with P15 (t.i. at E19.5) (**Po0.01) (b) (c)
Double immunostaining with anti-GFP and anti-NeuN at later tamoxifen injection (at P7) and analysis (at P60) showed that GFP-positive BG were not neurons in the
cerebellum. (d) Sagittal sections double immunofluorescence stained with anti-GFP and anti-Olig2. Olig2 immunoreactivity was not observed in EYFP-positive BG, but present
in EYFP-positive cells in the granular layer. (e) The Purkinje cell marker calcium binding protein (CaBP) staining at P15 showed no specific EYFP expression in the Purkinje
cells in the cerebellum. Abbreviations: AC, astrocyte; BG, Bergmann glia; gl, granule cell layer; ml, molecular layer; pcl, Purkinje cell layer; t.i., tamoxifen injection; wm, white
matter. Scale bars: (c and d)¼ 100mm; (e)¼ 25mm
Figure 2 Plp-expressing NG2þ cells also give rise to astrocytes and Bergmann glia (Part 1). (a) Double-immunofluorescence labeling of P15 sections with anti-
GFP and anti-GFAP in the PCE/R mouse cerebellum showed that EYFPþ cells were able to give rise to astrocytes. Tamoxifen was injected at E19.5. (a’ and a’’) represent
the rectangular area of (a). (b) Double immunofluorescence with anti-GFP and the pan-neuronal marker anti-NeuN showed no colocalization in the molecular and the Purkinje
cell layers of the cerebellum. (c and d) Double immunostaining with anti-GFP and anti-GFAP (red) showed that EYFPþ cells gave rise to astrocyte and Bergmann glia at P15
cerebellum (t.i. at E19.5). (e) EYFPþ Bergmann glia was obvious in the lateral part of cerebellar lobule X. (e’ and e’’) represent the rectangular area of (e). (f and h) Double
immunofluorescence staining with anti-GFP and anti-GFAP showed that EYFPþ Bergmann glia expressed GFAP. (g) EYFPþ Bergmann glia was more abundant when
tamoxifen was injected at P7 and sections analyzed at P60. Abbreviations: gl, granule cell layer; ml, molecular layer; pcl, Purkinje cell layer; PPEP, Plp-expressing progenitor
cells; t.i., tamoxifen injection; wm, white matter. Scale bars: (a)¼ 50mm; (b)¼ 150mm; (e)¼ 250mm; (f and h)¼ 100mm; (g)¼ 125mm
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Tamoxifen was injected at P0 followed by subsequent MK-
801 or NBQX treatment. We found that the general
distribution profile and pattern of EYFP-positive cells were
overall indistinguishable between the control (Figure 7a) and
NBQX treatment (Figure 7b). Normal development of EYFP-
positive BG was somewhat impaired (Figure 7d) compared
with saline-treated control (Figure 7c). In the control group,
EYFP-positive radial processes corresponding to those of
BG were densely arranged within the cortex (Figures 7c and
c’). Most of the processes extended from the somata to pial
boundary of surface, which were aligned in the Purkinje cell
layer (Figures 7c and c). However, MK-801-treated EYFP-
positive BG processes were not aligned in the cortex and did
not reach the pial surface (Figures 7d and d’). In addition,
when analyzed at P24, the number of EYFPþ BG was
significantly decreased in MK-801-treated group compared
with the control (Figures 7h and i, Po0.001). These results
indicate that glutamate receptor antagonist treatment generally
did not alter NG2þ cell fates, but NMDA glutamate receptors
does appear to play a role in normal development of BG.
Hypoxic–ischemic brain injury does not alter the cell fate
of NG2þ cells, but the number of oligodendroglial cells
is increased. NG2þ cells proliferate in response to injury,1
and previous studies have suggested that injury or disease
can reprogram NG2þ cell fates.31–33 We examined whether
fate alterations of NG2þ progenitor cells could occur in our
established hypoxic–ischemic model of neonatal brain injury
in mice.19,20 In this mouse model, which reliably resembles
the pathology of periventricular leukomalacia (PVL) in
premature infants, NG2þ progenitor cells are a major
substrate of the disease. In addition, PVL injures the
cerebellum as well as the telencephalon.34–38 We thus
investigated whether PVL-like injury might alter the fates of
Olig2-expressing NG2þ cells. Hypoxic–ischemic brain injury
was induced in P6 OCE/R mouse pups, and cerebellar
sections were analyzed at P11. In the hypoxic–ischemic
cerebellum, the basic topography of EYFP-positive cells was
not significantly changed (Figures 8a–d). Next, immunostain-
ing for myelin basic protein (MBP) was performed to evaluate
the severity of white matter injury. MBP-positive oligoden-
drocyte/myelin formation did not appear to be affected in the
cerebellum (Figures 8c–f). In addition, neither the number of
EYFPþGFAPþ astrocytes and BG (Figure 8i) nor basic
topography of these cells (Figures 8a) was different between
the control and hypoxic–ischemic mice. However, we found
that the number of EYFPþO1þ oligodendroglial cells in the
cerebellum was increased in response to hypoxic–ischemic
injury in the PVL mice compared with the controls (Figures
8g, h, and i, Po0.01), likely because of a reactive response
to hypoxia–ischemia.
Discussion
The fate of NG2þ cells has been a controversial issue for
decades.39 In addition, previous studies have largely, if not
exclusively, focused on examining NG2þ cell fates in the
forebrain and spinal cord. In the present study, we have
focused our attention on the cerebellum. Taking advantage of
Plp and Olig2 promoter activity in NG2þ cells to drive
expression of a tamoxifen-inducible Cre transgene,
we generated PCE/R and OCE/R double-transgenic mice.
Consistent with previous findings on NG2þ cell fates, we
observed abundant oligodendrocyte differentiation in these
mice. Thus, NG2þ cells give rise primarily to oligodendro-
cytes. Surprisingly, however, we discovered that a significant
fate of the NG2 progenitors is BG in both the PCE/R and OCE/
R mouse cerebellum. We also searched among the EYFP-
positive cells for evidence of astrocytes or neurons.
We observed a portion of the cells bearing the astrocyte
marker GFAP and the characteristic astrocytic morphology in
both the Plp-Cre and the Olig2-Cre mice. We did not observe
EYFP-positive neurons in the OCE/R mice, indicating that
NG2 progenitors do not give rise to neurons. We did, however,
spot the occasional NeuN-positive neurons expressing EYFP
in the PCE/R mouse cerebellum, but these cells were
extremely rare and only found in the cerebellar nuclei region.
We showed that those few EYFPþ neurons were not new
neurons arising from NG2þ progenitors, because they were
apparent 24 h after tamoxifen treatment, yet it should take
weeks or longer for neurons to be derived from NG2þ cells.
Therefore, those few neurons ectopically expressing EYFP
must have been already neurons or nearly differentiated
neurons that happened to express the Plp promoter at the
time of tamoxifen treatment. However, the EYFPþ labeling of
astrocytes and BG clearly was not ectopic. We showed that
the ectopic expression of EYFP 24 h after t.i. was only seen in
the few neurons in the cerebellar nuclei region (Figure 6h),
and not in any other regions and cell types including
astrocytes and BG in the PCE/R mouse cerebellum
(Figure 6i), and there was no any ectopic expression of EYFP
in the OCE/R mouse cerebellum.
Raff et al.3 indicated that OPCs could generate either
oligodendrocytes or type-2 astrocytes in cultures of rat optic
cells. More recently, fate mapping techniques using geneti-
cally engineered Cre–loxP system have enabled us to
examine the fates of NG2þ cells directly in vivo. Using
NG2-Cre BAC transgenic mice to trace the progeny of NG2
glia, Zhu et al.11,12 demonstrated that a large number of fate-
mapped astrocytes were found in the gray matter of the
ventral forebrain and spinal cord. In addition, a number of
studies indicated that NG2þ cells generate neurons as well
as oligodendrocytes and astrocytes.4,9,40 Kondo and Raff4
showed that OPCs could revert into neural stem cells that
Figure 4 Olig2-expressing NG2þ cells primarily generate oligodendrocytes in the mouse cerebellum. (a and b) Single immunofluorescence labeling for anti-GFP
in the Olig2-Cre-ER/Rosa26-EYFP (OCE/R) mouse cerebellum. Tamoxifen was injected at P5 and sections analyzed at P8 (a). Tamoxifen was injected at P6 and analyzed at
P11 (b). In both cases, strong EYFP-positive cells were observed throughout the cerebellum. (b’ and b’’) High-power images of the rectangular region of (b). EYFP-positive
Bergmann glia-like cells were obvious in the molecular and the Purkinje cell layers of the cerebellum (b’). There were abundant EYFP-positive profiles in the white matter (b’’).
(c and -d) Double immunofluorescence labeling with anti-GFP (green) and anti-O1 (red) showed that some EYFP-positive cells coexpressed O1. Quantification of the
percentile of O1þ and PDGFRaþ oligodendrocyte lineage cells in the white matter (d). Abbreviations: gl, granule cell layer; ml, molecular layer; pcl, Purkinje cell layer; t.i.,
tamoxifen injection; wm, white matter. Scale bars: (a and b)¼ 100mm; (c)¼ 25mm
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could then give rise to neurons, oligodendrocytes, and
astrocytes. Further studies supported this idea. In CNP-
EGFP mice, NG2-expressing cells generated neurons as well
as oligodendrocytes, both in culture5 and after being grafted
into neurogenic areas of the embryonic or postnatal host
brain.6,7 Using Cre–Lox fate mapping studies, others further
suggested that NG2 glia could give rise to neurons in the
forebrain subventricular zone (SVZ) and hippocampus.9,13,40
Figure 5 Olig2-expressing NG2þ cells also give rise to astrocytes and BG. (a–d) Double immunofluorescence labeling of P11 sections with anti-GFP and anti-
GFAP in the OCE/R mouse cerebellum. There were double-labeled cells immunopositive for EYFP and GFAP confirming that they were astrocytes (a and a’). Tamoxifen was
injected at P6. (a’) A higher magnification and separate view of the region indicated in (a). (b–d) Double immunostaining with anti-GFP (green) and anti-GFAP (red) showed
that Olig2-Cre expression was present in BG at the P11 cerebellum. (e–g) Double immunofluorescence labeling of P11 sections with anti-GFP and anti-Olig2 showed that
Olig2þ cells were not colabeled with EYFPþ BG. (h and i) Quantification of the percentile of EYFPþ and GFAPþ astrocytes (h) and BG (i) out of the whole GFAPþ cells
(*Po0.05). Abbreviations: AC, astrocyte; BG, BG; gl, granule cell layer; ml, molecular layer; pcl, Purkinje cell layer; t.i., tamoxifen injection. Scale bars: (a, b, and e)¼ 100mm
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Figure 6 NG2þ cells do not give rise to neurons in the OCE/R mouse cerebellum, and a very small subset of cerebellar nuclei neurons in the PCE/R mouse
cerebellum ectopically express EYFP. (a–c) Immunofluorescence labeling with the neuronal marker NeuN revealed that EYFP-immunopositive cells did not express NeuN
in the granular layer and in the white matter of the OCE/R cerebellum. (d–f) Sagittal sections of P15 PCE/R mouse cerebellum immunofluorescence stained with anti-GFP and
anti-NeuN after t.i. at E19.5. A few EYFP-positive cells were colabeled with anti-NeuN representing a very small subset of ectopically EYFP-labeled cerebellar nuclei neurons.
(g) Double immunofluorescence labeling of P60 sections with anti-GFP and anti-NeuN in PCE/R mouse cerebellum showed no double-labeled cells. (h and i) Ectopic EYFP
staining 24 h after tamoxifen injection in the PCE/R mouse cerebellum. (h) Similar to those seen in (d–f), ectopic expression of few EYFPþ neurons could only be found in the
cerebellar nuclei areas. (i) No ectopic EYFP expression in any cell types in the cortex and white matter of the cerebellum. Abbreviations: gl, granule cell layer; ml, molecular
layer; pcl, Purkinje cell layer; t.i., tamoxifen injection; wm, white matter. Scale bars: (b, d–h)¼ 50mm; (i)¼ 125mm
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Figure 7 MK-801 treatment impairs the normal development of BG. (a and b) Single immunofluorescence labeling with anti-GFP in the PCE/R mouse cerebellum after
treatment of NBQX. Tamoxifen was injected at P0 and sections analyzed at P24. General distribution profile and pattern of EYFP-positive cells were normal for both the control
(a) and NBQX treatment (b). (c and d) Single immunofluorescence labeling with anti-GFP in the PCE/R mouse cerebellum after MK-801 treatment. Tamoxifen was injected at
P0 and sections analyzed at P13 and P24. The general morphology of EYFP-positive BG was impaired (d) compared with the control (c). (e–g) The number of EYFPþ BG
was significantly decreased in the MK-801 treatment group (f and g). (h and i) Quantification of the number of EYFPþ /GFAPþ BG after NBQX or MK-801 treatment
(***Po0.001). Abbreviations: BG, Bergmann glia; gl, granule cell layer; ml, molecular layer; pcl, Purkinje cell layer; t.i., tamoxifen injection. Scale bars: (a and b)¼ 100mm;
(c–g)¼ 125mm
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NG2þ cells in the neocortex and piriform cortex expressed
doublecortin, a marker of migratory neuronal progenitors in
the forebrain.40 Some NG2þ cells in the piriform cortex
expressed Sox2 and Pax6,9,40 two neural stem cell markers.
However, the neuronal fate of NG2þ cells was not observed
by other studies using the NG2 or PDGFRa antibody to label
SVZ or hippocampal stem cells or to detect NG2 or PDGFRa
promoter activity in these stem cell populations in BAC
transgenic mice.8,11,14,41 Zhu et al.11,12 reported that no
neurons were generated from NG2 progenitors in constitutive
NG2–Cre mice. In addition, no YFP-positive neurons were
found in Olig2-Cre/Rosa YFP mice.42
Several factors contribute to the controversies regarding
NG2 cell fates. First, the expression of PDGFRa, NG2, Olig2,
or Plp are not exclusive in NG2þ cells, making NG2þ cell-
fate mapping less straightforward, and if the targeted genes
were not specific to NG2þ cells at the time of t.i., the integrity
of the genetic cell-fate tracing experiments would be
compromised. Therefore, checking for the reporter EYFP or
Cre ectopic expression in the cerebellum shortly (e.g., 24 h)
after t.i. was critical for the fate mapping studies. Moreover,
the rarity and anatomical location of EYFP-positive neurons
could make them difficult to detect. In our Plp-Cre lineage
tracing experiments, very few EYFP-positive neurons were
observed only in the cerebellar nuclei region, and we
demonstrated that they were ectopically labeled neurons
and were not directly derived from NG2þ cells. In addition,
we sought to obtain consistent data using two different lines of
transgenic mice and to double confirm results for each other.
In addition, we showed that Cre expression was specific to
NG2þ cells at the time points of t.i., indicating that NG2þ cells
generate BG and astrocytes in the mouse cerebellum. We found
Figure 8 Hypoxic–ischemic injury does not result in fate changes in the OCE/R mouse cerebellum, but the number of oligodendrocyte lineage cells is
increased. (a–f) Immunofluorescence labeling of EYFP and MBP in the OCE/R mouse cerebellum after induction of neonatal brain injury using a mouse model of PVL.
Tamoxifen was injected at P0 and sections analyzed at P11. The number and anatomical topography of EYFPþ cells were not significantly changed between the control
(a) and the hypoxic–ischemic cerebellum (b). The topography of MBP-positive oligodendrocytes in the cerebellum was relatively normal after hypoxic–ischemic injury (c and e:
control; d and f: PVL). (g and h) Double immunostaining with anti-GFP and anti-O1 showed abundant double-labeled cells in the granular layer. (i) Quantification of the
percentile of EYFPþ cells that expressed GFAPþ for astrocytes and BG, PDGFRa for oligodendroglial precursor cells, and O1 for oligodendroglial cells in the cerebellum
after PVL induction. The number of EYFPþ /O1þ oligodendroglial cells was increased after PVL induction (**Po0.01). Abbreviations: AC, astrocyte; BG, Bergmann glia;
Ctrl, control; gl, granule cell layer; ml, molecular layer; pcl, Purkinje cell layer; PVL, periventricular leukomalacia; t.i., tamoxifen injection; wm, white matter. Scale bars:
(a–d)¼ 100mm; (h and g)¼ 125mm; (j and i)¼ 250mm
Fate of Olig2/Plpþ progenitors in mouse cerebellum
S-H Chung et al
11
Cell Death and Disease
that cerebellar NG2þ cells gave rise to astroglia after prenatal
tamoxifen administration, and to BG after postnatal tamoxifen
administration, in an age-dependent manner.
Regarding the development of BG, a previous report
showed that GLAST-expressing cells in the external granular
layer were present as early as E14 in the embryonic
cerebellum.25 Cells expressing tenascin or GLAST had
increased further and densely located beneath the multi-
cellular layer of Purkinje cells by E18.43–45 During the first
postnatal week when Purkinje cells establish monolayer
alignment, cells expressing tenascin or GLAST are further
compacted to form an epithelium-like lining in the Purkinje cell
layer. Our study demonstrated that later P7 t.i. labeled more
BG than earlier E19.5 t.i., suggesting that BG generation in
the cerebellum is predominately postnatal.
After having revealed a previously unrecognized BG fate of
NG2þ progenitors, we then examined the mechanisms of the
cell-fate control in the cerebellum. Given the known role of
glutamate-triggered calcium signaling in shaping the BG cell
fate in mice, we used ionotropic glutamate receptor (NMDA
versus non-NMDA type) antagonists to study the involvement
of glutamate signaling in the regulation of the BG fate of
NG2þ progenitors, and found that NMDA-type glutamate
receptors play a role in the normal development of BG.
Karadottir et al.46 documented oligodendroglial NMDA recep-
tors in the cerebellum, although recent studies47,48 empha-
sized that these receptors are few in number and that their
deletion does not affect oligodendrocyte development. Inter-
estingly, within this context, our results described here would
instead suggest that these NMDA receptors might modulate
development of BG in the cerebellum.
In addition, NG2þ cells are known to proliferate in
response to injury,1 and studies have suggested that following
trauma, NG2þ cells give rise to astrocytes as well as
microglia32 and Schwann cells.33 Furthermore, NG2þ cells
proliferate and generate astrocytes in ALS.31 We examined
whether there might be alterations in the fates of NG2þ
progenitor cells in a hypoxic–ischemic model of neonatal brain
injury.19,20 In this model, where NG2þ progenitor cells are a
major substrate of the pathology, we found that, despite a
reactive response of the O1þ oligodendroglial cells to injury,
the fates of the NG2-expressing cells remain unchanged, with
a similar multipotential capacity of giving rise to oligoden-
drocyte lineage cells, BG, and astrocytes in the cerebellum.
Thus, the multipotential capacity of the NG2þ progenitor
cells remains the same in health and disease.
Overall, by revealing a novel BG fate of Olig2/Plp-positive
NG2 progenitors, our findings reported here represent a
conceptual advance. Our study provides important insights into
not only the differentiation of NG2þ cells into various functional
glial cell types in the mouse cerebellum but also more generally
in the functional role of the progenitor cells in health and disease.
Materials and Methods
Transgenic mice. All animal procedures conformed to institutional regula-
tions of the University of California at Davis and guidelines of the NIH. Mice were
housed in animal facilities of the University of California at Davis with a 12-h light/
dark cycle and free access to food and water. The Plp-CreERT2 mice15 and
Rosa26-EYFP reporter line49 were purchased from The Jackson Laboratory (Bar
Harbor, ME, USA) and maintained in the C57BL/6 background. These two lines
were crossed to obtain PCE/R double-transgenic mice. In PCE/R mice, Cre-ERT2
fusion protein is expressed in the cytosol under the control of Plp promoter. After
binding with tamoxifen, Cre recombinase translocates into the nucleus to mediate
Cre–loxP recombination, thus eliciting permanent expression of the EYFP reporter
gene in the Plp promoter-driven EYFP-expressing progenitors and their progenies.
Olig2-Cre-ER transgenic mice18 were crossed to Rosa26-loxP-STOP-loxP-EYFP
reporter transgenic mice49 to yield OCE/R transgenic mice, which carried a
heterozygous Cre transgene and homozygous reporter transgenes. All mice were
maintained on the C57BL/6 background. Both males and females were used in this
study.
Mouse model of periventricular leukomalacia. A model of neonatal
brain injury, which reliably resembles the neuropathology of PVL,19,20 was induced
in P6 mouse pups using ischemia induced by unilateral carotid ligation (UCL) and
followed by hypoxia, which resulted in selective injury to the periventricular white
matter. In brief, mice were anesthetized under ice (indirect cooling) and then
underwent UCL followed by a 1-h recovery interval during which the pups were
housed with the dam and kept on a thermal blanket to maintain body temperature
at 33–34 1C. Next, the pups were placed in an airproof isolation chamber with
6.0% O2 for 35min. After exposure to hypoxia, pups were housed with the dam for
intervals of 24, 48, 72, or 96 h, as required for further experiments.
Drug treatments. Tamoxifen (T5648; Sigma-Aldrich, St. Louis, MO, USA)
was dissolved in an ethanol/sunflower seed oil (1 : 19) mixture at a concentration
of 10mg/ml. At P7, PCE/R pups were injected twice, 6–8 h apart intraperitoneally
with tamoxifen (75 mg/g body weight). Glutamate receptor antagonist MK-801
(Sigma, St. Louis, MO, USA) at 1mg/kg or NBQX (Tocris Cookson, St. Louis, MO,
USA) at 30mg/kg was given by intraperitoneal injection at P0 with t.i. Lesioned
control animals were injected with PBS. These mice were killed 4 days after drug
treatment. There were no apparent behavioral effects after injection of either of the
antagonist drugs. Animals continued to drink, eat, and groom like controls.
Antibodies. Two anti-green fluorescent protein (GFP) antibodies, both of
which crossreact with and identify EYFP, were used, one a rabbit polyclonal
antibody and the other a mouse monoclonal antibody (1 : 1000; Abcam,
Cambridge, MA, USA). Anti-rabbit GFAP (1 : 1000) was raised against purified
bovine GFAP as an immunogen and used to mark astrocytes. Rabbit Anti-NG2
chondroitin sulfate proteoglycan polyclonal antibody (1 : 250; Millipore, Bedford,
MA, USA) was raised against immunoaffinity purified NG2 chondroitin sulfate
proteoglycan from rat. MBP (1 : 500; Sternberger and Sternberger, Baltimore, MD,
USA) as a protein marker for myelin and O1 (1 : 500; Millipore) as a lipid marker
for oligodendroglial cells were used. Rabbit polyclonal Olig2 antibody (1 : 500;
Abcam) was generated with a synthetic peptide from the N-terminal region of
human Olig2, conjugated to an immunogenic carrier protein. Two different mouse
monoclonal anti-calbindins were used: anti-calbindin-D-28K (clone CB-955, ascites
fluid, IgG1 isotype, raised against bovine kidney calbindin, 1 : 1000; Sigma), and
calbindin D-28K raised against chicken that specifically stains the 45 Ca-binding
spot (McAb 300, lot 18(F), 1 : 1000; Swant, Bellinzona, Switzerland). Both
antibodies yielded Purkinje cell-specific staining identical to that reported
previously.26,28 Anti-parvalbumin (ascites fluid, 1 : 1000; Sigma), a monoclonal
antibody secreted by the PARV-19 hybridoma cell line, was produced by
immunization with purified frog muscle parvalbumin. Rabbit polyclonal anti-
PDGFRa antibody (1 : 350, Abcam) was generated by immunization of synthetic
peptide derived from internal sequence of human PDGFRa. Mouse anti-neuronal
nuclei (NeuN) monoclonal antibody (1 : 500; Millipore) was generated by
immunization of purified cell nuclei from mouse brain, and was used to detect
postmitotic neurons.
Immunohistochemistry. Mice were deeply anesthetized with sodium
pentobarbital (100mg/kg, i.p.) and transcardially perfused with 0.9% NaCl in
0.1 M phosphate-buffered saline (PBS, pH 7.4) followed by 4% paraformaldehyde
in 0.1 M PBS (pH 7.4). The brains were then removed from the skull and post-fixed
in 4% paraformaldehyde at 4 1C for 48 h. The cerebella were cryoprotected
through a series of buffered sucrose solutions: 10% (2 h), 20% (2 h), and 30%
(overnight), and then embedded in OCT and frozen for cryosectioning. Transverse
sections were cut on a cryostat at 40 mm thickness through the extent of the
cerebellum and collected as free-floating sections for immunohistochemistry.
Cerebellar sections for fluorescent immunohistochemistry were processed as
described previously.50 Briefly, tissue sections were washed thoroughly blocked
with 10% normal goat serum (Jackson ImmunoResearch Laboratories, West Grove,
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PA, USA) and then incubated in 0.1 M PBS containing 0.1% Triton-X and the
primary antibody for 16–18 h at 4 1C. Sections were then rinsed and incubated for
2 h at room temperature in a mixture of Alexa 546-conjugated goat anti-rabbit IgG,
Alexa 488-conjugated goat anti-mouse IgG, and Alexa 643-conjugated goat anti-
mouse pig IgG (Molecular Probes Inc., Eugene, OR, USA) in a 1 : 2000 dilution.
After several rinses in 0.1 M PBS, sections were cover-slipped in non-fluorescing
mounting medium (Fluorsave Reagent, Calbiochem, La Jolla, CA, USA).
Photomicrographs were captured with a SPOT Cooled Color digital camera
(Diagnostic Instruments Inc., Sterling Heights, MI, USA), mounted on a Zeiss
microscope (Thornwood, NY, USA), and assembled using Adobe Photoshop
(version 9; San Francisco, CA, USA) without manipulation.
Statistical analysis. Data are presented as mean±S.E.M. Each experi-
mental group had at least six mice. All immunohistochemical analyses were
performed in triplicate. Analysis of variance (ANOVA) with Tukey’s post hoc tests
were used to compare differences between groups for all quantitative analyses.
Statistical significance was accepted at Pr0.05.
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